Literature DB >> 17558327

Retinal pigment epithelium produces matrix metalloproteinases after laser treatment.

Christina Flaxel1, John Bradle, Ted Acott, John R Samples.   

Abstract

PURPOSE: To evaluate production of matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) after panretinal photocoagulation (PRP) of human retinal pigment epithelium (RPE) explants.
METHODS: Treated explants were subjected to substrate zymography to differentiate MMP-2 from MMP-9 and dot immunoblot analysis to quantify MMP-3 and TIMP activity. Tritiated thymidine uptake by RPE cells was measured to document evidence of cellular division in the laser-treated versus control explants.
RESULTS: We detected MMP-2, MMP-3, and TIMP-1. MMP-2 and MMP-3 secretion increased to twice the control values. TIMP decreased until day 4 and then increased by day 6. Tritiated thymidine uptake increased 2.5-fold until day 6, returning to baseline by day 8.
CONCLUSION: PRP disturbs MMP/TIMP balance, inhibiting the initiation and maintenance required for active neovascularization. The efficacy of PRP may be due to changes in the expression pattern of metalloproteinases and inhibitors. This model elucidates the possible contribution of PRP to neovascularization regression by demonstrating the effect of laser on TIMP/MMP balance. The effects of PRP may be much more complex than currently understood and most likely involve more than vascular endothelial growth factor and other ischemia-related factors.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17558327     DOI: 10.1097/01.iae.0000249561.02567.fd

Source DB:  PubMed          Journal:  Retina        ISSN: 0275-004X            Impact factor:   4.256


  23 in total

1.  Subthreshold diode laser micropulse photocoagulation versus intravitreal injections of bevacizumab in the treatment of central serous chorioretinopathy.

Authors:  M J Koss; I Beger; F H Koch
Journal:  Eye (Lond)       Date:  2011-11-11       Impact factor: 3.775

2.  [Treatment of central serous chorioretinopathy: MicroPulse photocoagulation versus bevacizumab].

Authors:  I Beger; M J Koss; F Koch
Journal:  Ophthalmologe       Date:  2012-12       Impact factor: 1.059

3.  Regulation of surface expression of TRPV2 channels in the retinal pigment epithelium.

Authors:  Nadine Reichhart; Susanne Keckeis; Frederik Fried; Gabriele Fels; Olaf Strauss
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-01-24       Impact factor: 3.117

4.  Laser and anti-vascular endothelial growth factor treatment for drusenoid pigment epithelial detachment in age-related macular degeneration: 24-month outcomes.

Authors:  Hyeong Min Kim; Na-Kyung Ryoo; Kyu Hyung Park
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2022-03-21       Impact factor: 3.535

5.  Safety and efficacy of selective retina therapy (SRT) for the treatment of diabetic macular edema in Korean patients.

Authors:  Young Gun Park; Jae Ryun Kim; Seungbum Kang; Eric Seifert; Dirk Theisen-Kunde; Ralf Brinkmann; Young-Jung Roh
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-01-23       Impact factor: 3.117

6.  Prediction of regression of retinal neovascularisation after panretinal photocoagulation for proliferative diabetic retinopathy.

Authors:  Irini P Chatziralli; Theodoros N Sergentanis; Sobha Sivaprasad
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-01-22       Impact factor: 3.117

7.  Application of subthreshold laser therapy in retinal diseases: a review.

Authors:  Spencer M Moore; Daniel L Chao
Journal:  Expert Rev Ophthalmol       Date:  2018-12-11

Review 8.  Subthreshold diode micropulse laser photocoagulation (SDM) as invisible retinal phototherapy for diabetic macular edema: a review.

Authors:  Jeffrey K Luttrull; Giorgio Dorin
Journal:  Curr Diabetes Rev       Date:  2012-07-01

9.  Efficacy of Ethanol Extract of Fructus lycii and Its Constituents Lutein/Zeaxanthin in Protecting Retinal Pigment Epithelium Cells against Oxidative Stress: In Vivo and In Vitro Models of Age-Related Macular Degeneration.

Authors:  Xinrong Xu; Li Hang; Binglin Huang; Yuanhua Wei; Shizhong Zheng; Wei Li
Journal:  J Ophthalmol       Date:  2013-09-12       Impact factor: 1.909

10.  Matrix Metalloproteinase-1 and Matrix Metalloproteinase-9 in the Aqueous Humor of Diabetic Macular Edema Patients.

Authors:  Jin-Woo Kwon; Jin A Choi; Donghyun Jee
Journal:  PLoS One       Date:  2016-07-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.